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Abstract: Conducted electrical weapons (CEWs) have potential as effective alternatives

to chemical restraint for short-term nonroutine capture and handling of wildlife. To assess
immediate and delayed physiologic effects of exposure to a CEW, we assigned 15 captive
reindeer (Rangifer tarandus tarandus) to 1 of 3 treatment groups: immobilized with carfentanil
and xylazine (CX), 10-second exposure to a CEW, or exposure to the CEW while immobilized
with CX (CEW+CX). Blood samples were collected pre-treatment, immediately postintervention, 10 minutes, 20 minutes, 4 hours, and 24 hours post-intervention. Physiologic
effects were evaluated by analysis of blood, clinical observation for signs of physiologic
compromise, and vital signs. Parameters that changed significantly (P < 0.05) postexposure (lactate, glucose, rectal temperature, blood oxygen, cardiac troponin I, cortisol,
and catecholamines) were not significantly different from baseline values within 24 hours.
Cortisol, glucose, and peak rectal temperature were lower in CEW-exposed individuals, while
lactate, oxygen, and catecholamines were higher than for the CX-exposed individuals. The
catecholamine response observed in the CEW-only group paralleled the response in the
CEW+CX group. No long-term health effects were detected from either restraint method. Use
of a CEW does not appear to increase the risk of capture myopathy.
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Effective wildlife management includes
efficient and safe methods for short-term restraint
to reduce stress on animals while facilitating
actions such as sample collection, restraint,
handling for the purpose of relocation, or release
from snares or entanglements. Chemical restraint
is frequently used but may not be appropriate in
all situations, such as when there is a risk to the
public from misdirected projectiles, restrictions
on use of projectors considered firearms, or from
exposure to controlled substances (e.g., opioids)
from darts or drug residue in meat salvaged
for consumption. Additionally, many of the
drugs used for chemical restraint are controlled
substances, and trained personnel that can
legally administer them are not always available.
Darting and chemical restraint also have
inherent risks to wildlife including injury and
capture mortality (Kock et al. 1987). Conducted
electrical weapons (CEWs; Figure 1) are being
used as a nonlethal alternative for short-term
(<1 min) restraint or hazing (Lewis et al. 2011).
Interest is high among wildlife agencies in

the efficacy of this tool. Preliminary research
was undertaken by Alaska Department of Fish
and Game Division of Wildlife Conservation
at the Kenai Moose Research Center (Sterling,
Alaska, USA) to evaluate CEW effects on
moose (Alces alces; K. B. Beckmen, Alaska
Department of Fish and Game, unpublished
data), and those results were considered when
designing this study as well as for developing
a standard operating procedure for CEW use
by the Alaska Department of Fish and Game
(2010). Since then, Alaska Department of Fish
and Game Division of Wildlife Conservation
personnel have used CEWs for human safety
while temporarily restraining wildlife, such as
moose, to remove them from entanglements
(Lewis et al. 2011). For example, as an alternative
to killing a cow moose, a CEW has been used
to protect personnel from an aggressively
protective cow in order to rescue her calf that
had gotten trapped in an open pit (Lewis et
al. 2011). Additionally, a CEW has been used
for hazing and aversive conditioning in >400

Conducted electrical weapons • Lieske et al.

Figure 1. TASER X2 device (TASER International,
Scottsdale, Arizona, USA). Axon/TASER does not
endorse the use of their products for wildlife usage.

bears (Ursus spp.) between 2010 and 2017 at
Port Armstrong, a remote fish hatchery on
Baranof Island near Sitka, Alaska, USA and at
other locations around Alaska. Application of
CEWs to bears led to greater human avoidance
behavior and decreased returns to the humanoccupied areas of the fish hatchery compared
to the use of other standard hazing methods
(P. Mooney, Alaska Department of Fish and
Game, unpublished data).
Conducted electrical weapons have widespread use by law enforcement agencies for the
restraint of humans. In humans, CEWs have
been found to reduce the rate and severity of
injuries in both suspects and officers (Smith
et al. 2007, Bozeman et al. 2009). However,
there are still safety concerns, including their
contribution to arrest-related deaths (Bozeman
et al. 2009, Jauchem 2015). Many of the concerns,
especially potentially fatal cardiac effects (such
as ventricular fibrillation) and acidosis (from
increased lactate), although not reported in
humans, are based on animal model studies.
These animal studies have been mostly done
in pigs (Sus sp.; Walter et al. 2008, Jauchem et
al. 2009, Jauchem 2015), where prolonged or
repeated discharges and location of the probes
(such as transcardiac positioning or direct
chest exposures) may be factors. In humans,
physiological changes (including measures of
stress, acidosis, and cardiovascular disruption)
from exposure to CEWs have been no greater
than those seen with other law enforcement
nonlethal restraint methods (Ho et al. 2008,
Dawes et al. 2009, Ho et al. 2009a, Ho et al.
2009b, Ho et al. 2010).
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The American Veterinary Medical Association
does not currently recommend the use of electroimmobilization, such as with a CEW, for routine
capture or restraint of animals (AVMA 2008,
AVMA 2010). The concern with their use is the
potential for distress and physical discomfort
to an animal. Their use has been considered
potentially appropriate in emergency or lifethreatening situations when dealing with an
aggressive or dangerous animal. It is not the
intent of this paper to recommend the use of
CEWs for routine capture. The goals of this
study are to better understand the effects of
CEWs on animals to evaluate their potential use
in management situations when other methods
(such as chemical immobilization) are not
available or practical.
Because of the concern for capture myopathy
(or exertional rhabdomyolysis) in wildlife, it
is critical to ascertain that use of a CEW does
not add more stress than is already associated
with capture and handling. Capture myopathy
is a syndrome that leads to fatality and is seen
in situations after prolonged or severe stress or
exertion in animals. It is characterized by muscle
(skeletal and cardiac) necrosis and renal failure.
Acidosis (low blood pH, often due to increased
lactic acid) and hyperthermia may exacerbate
the condition (Williams and Thorne 1996).
The goal of this study was to assess the
immediate and delayed physiologic effects of
exposure to a CEW and compare them to the
effects of chemical restraint using carfentanil
and xylazine (CX), the standard drug
combination for wildlife capture and handling
in the state of Alaska. Readily available captive
reindeer (Rangifer tarandus tarandus) were
used as a model for barren-ground caribou (R.
tarandus granti) in this study. We hypothesized
that the physiological effects of a CEW would
not be significantly different than chemical
restraint, and thus, would not pose a greater
risk of capture myopathy.

Methods

In June 2014, 15 adult female reindeer housed
at the Robert G. White Large Animal Research
Station (University of Alaska Fairbanks
Institute of Arctic Biology, Fairbanks, Alaska,
USA) and habituated to physical restraint
and blood collection were assigned to 1 of 3
treatment groups (n = 5 for each treatment):
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immobilized (hand injection IM) with CX (0.03
mg/kg carfentanil and 0.3 mg/kg xylazine), a
10-second exposure to a CEW, or a 10-second
exposure to the CEW while immobilized with
CX (CEW+CX).
For CEW interventions, a TASER X3W®
wildlife-specific handheld conducted electrical
weapon (TASER International, Scottsdale,
Arizona, USA) was used (large animal setting).
The device has an open circuit arcing voltage of
50,000 V to achieve an arc to overcome resistance
to air, fur, and hide and complete a circuit
between the 2 wired probes through which the
charge is delivered. When a circuit is complete,
the voltage drops to approximately 1,200 V and
the device delivers pulsed electricity consisting
of 85–130 microcoulombs of charge per pulse
at a pulse rate of 29 pulses per second (0.0035
amperes).
Pre-treatment (T0) blood samples were
collected from each individual while halter
tied. Animals were then exercised for 5 minutes
by running them within the corridors between
pens to simulate a pre-darting excitement, then
brought into a chute for treatment. Subsequent
blood samples were collected at the following
time points: immediately (TC), 10 minutes (T1),
20 minutes (T2), 4 hours (T3), and 24 hours
(T4) post-intervention. For the immobilized
individuals, drugs were injected, and anesthesia
was induced (2–4 min) and maintained. After
10 minutes post-injection, naltrexone (100 mg
per mg of carfentanil given) and atipamazole
(1 mg per 10 mg of xylazine given) were
administered intravenously to antagonize the
effects. Recovery to standing occurred in 2–4
minutes. The TC for the individuals exposed to
the CEW was immediately after the device was
turned off; for the CX group, it was 10 minutes
after the drugs were administered (just before
antagonists were given). Behavior and vital
signs were monitored throughout exposure
and through recovery. Rectal temperature
was measured with a clinical digital rectal
thermometer.
Venous blood (from the jugular vein) was
collected in lithium heparin (6 ml Vacutainer,
Becton, Dickinson and Co, Franklin Lakes, New
Jersey, USA) and serum separator evacuated
tubes (8.5 ml Vacutainer, Becton, Dickinson
and Co, Franklin Lakes, New Jersey, USA).
Immediately after sampling, a subset of whole
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blood was tested using point of care devices.
EPOC (Heska, Loveland, Colorado, USA) was
used to determine pH, blood carbon dioxide
(pCO2), blood oxygen (pO2), sodium (Na+),
potassium (K+), chloride (Cl-), ionized calcium
(Ca++), creatinine, glucose, and hematocrit at
T0, T1, T2, and T3. Lactate Pro Analyzer (Arkray
Global Business, Kyoto, Japan) was used to
measure blood lactate at all 6 time points.
Samples were centrifuged for 10 minutes
at 1500 G (Clay Adams Triac centrifuge,
Becton, Dickinson and Co, Franklin Lakes,
NJ, USA). Serum and plasma were flash
frozen in liquid nitrogen, then stored at –80°C
until analyzed. The T0 and T3 serum were
sent to the University of Alaska Fairbanks
Animal Resources Center (Fairbanks, Alaska,
USA) for chemistry analysis on an Element
DC Veterinary Chemistry Analyzer (Heska,
Loveland, Colorado, USA) using test slides for
albumin, alkaline phosphatase (ALP), alanine
transferase (ALT), blood urea nitrogen (BUN),
total calcium, creatine kinase (CK), creatinine,
cholesterol, gamma-glutamyl transferase (GGT),
globulin, glucose, phosphorus, total bilirubin,
and total protein. Additional serum samples
(from T0, T1, T2, T3, and T4) were sent to
Texas A&M Veterinary Medical Diagnostic
Laboratory (College Station, Texas, USA) and
tested for cardiac troponin I (cTnI) using a
cardiac troponin I high sensitivity assay on
an ADVIA Centaur CP Ultra-TnI (Siemans
Healthcare, Tarrytown, New York, USA) and
serum cortisol using a solid phase, competitive
chemiluminescent
enzyme
immunoassay.
Plasma (from T0, TC, and T3) was analyzed at Ani
Lytics Incorporated (Gaithersburg, Maryland,
USA) for catecholamines (epinephrine and
norepinephrine) using a radio-immunoassay
(RIA) with an extraction/acylation prior to
assay. The reagents were obtained from ALPCO
(Salem, New Hampshire, USA).

Data analysis
Mean and SD were calculated for all
parameters. Additionally, the change from
baseline (results from T3 minus results from
T0) was calculated for blood chemistry results.
The T3 laboratory chemistry analysis results
for 1 individual (in the CEW+CX group) were
outside of the expected physiologic range
for most parameters. Comparing the results
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Figure 2. Mean ± SD for parameters to evaluate stress in captive reindeer (Rangifer tarandus tarandus)
whole blood (glucose), serum (cortisol), and plasma (catecholamines: norepinephrine and epinephrine)
collected at baseline (T0), immediately post-exposure (TC), 10 min (T1), 20 min (T2), 4 hours (T3), and
24 hours (T4) post-exposure to a 10-sec exposure to a conducted electrical weapon (CEW), immobilization with carfentanil/xylazine (CX), or to the CEW while immobilized with CX (CEW+CX). Open points (Δ =
CEW, ○ = CX, □ = CEW+CX) indicate values that differed significantly (P < 0.05) from T0 for that treatment. Points with different capital letters indicate treatments that differed significantly from the other treatments at that time point. Exposure occurred June 2014 in Fairbanks, Alaska, USA.

for glucose analyzed using the point of care
device (EPOC) to the glucose results from
the standard, benchtop laboratory chemistry
analyzer, it appears there was an error with the
laboratory results for that sample. There was
no difference in the significance of the results
whether the individual was retained or omitted
from the analysis. When reporting means and
ranges, the individual was omitted.
Glucose (serum chemistry and EPOC) and
lactate (EPOC and Lactate Pro) results were
found to be consistent between the different
testing methods (glucose, r2 = 0.90 for all time
points; lactate, r2 = 0.95 for lactate values <8
mmol/L and r2 = 0.75 for values >8 mmol/L),
so multiple comparison analyses were done
using results from the method with the most
data points (EPOC for glucose, Lactate Pro for

lactate).
Differences among groups were determined
using the Kruskal-Wallis nonparametric analysis
blocked by treatment group and sampling time.
For analyses where the global test was significant,
pairwise comparisons were calculated using the
Conover-Inman method. For all comparisons, P
< 0.05 was considered significant. Analyses were
done using Stats Direct (version 2.8.0, StatsDirect
Ltd., England 2013).

Results

For all comparisons, the results at T0
(baseline) did not vary significantly among
treatment groups.
Within each treatment group, results at T3 (4
hours post-intervention) were within an SD of
the results at T0 for serum chemistry parameters
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with the exception of glucose and CK. For
all treatment groups, CK was increased at T3
compared to T0 (P = 0.0016); however, there
was no significant difference among treatment
groups at either time point. The range that CK
increased was wide for all groups (339–9725
U/L for CX, 365–2543 U/L for CEW, 418–8144
U/L for CEW+CX).
Blood glucose (Figure 2) increased at T1 and
T2 for all groups (and was still significantly
elevated at T3 for the CX group). The increase
in glucose was greater in the CX-treated group
than the CEW group at T1 (P = 0.0017), T2
(P = 0.0019), and T3 (P = 0.003), although
results were not significantly higher than for
the CEW+CX group. Glucose in the CEW+CX
group was higher than the CEW group at T1
(P = 0.0038) and T2 (P = 0.0048). For 1 individual
in the CX group, blood glucose was measured
at 24 hours post-exposure and had returned to
baseline value (data not shown).
Cortisol (Figure 2) increased significantly
from T0 within all treatment groups, peaking
at T2 and decreasing to baseline by T3. The CX
individuals had higher cortisol values at both
T1 (P = 0.494) and T2 (P = 0.0375) than for the
CEW individuals. The CEW+CX group did not
vary significantly from either the CX or the
CEW-treated groups.
Both epinephrine and norepinephrine peaked
immediately after exposure to treatment for
the CEW and CEW+CX groups (Figure 2). The
values at TC were significantly higher for CEW
and CEW+CX than for CX. Catecholamine
levels decreased to baseline levels by T3.
There was no significant difference between
CEW and CEW+CX treatments at any time
point. Within treatment groups, epinephrine
decreased at TC compared to T0 or T3 for the
CX group (P = 0.0123); however, there was no
significant difference across time points for
norepinephrine.
Significant differences in hematocrit (P =
0.0066), pO2 (P = 0.0016), pCO2 (P = 0.0123),
and glucose (P < 0.0001) were found for whole
blood test using EPOC. Details of multiple
comparisons for significant differences
are further detailed below. No significant
differences in treatment or time point results for
pH, creatinine, Ca++, K+, or Na+ were found.
Hematocrit at T2 (37% ± 3.7) was lower
compared to T0 (42% ± 3.5) for the CX-treated
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group (P = 0.034). For the CEW+CX group,
hematocrit at T2 (39% ± 3.2; P = 0.0316) and T3
(39% ± 2.1; P = 0.0394) were lower than at T0
(43% ± 3.6). Although the hematocrit for the
CEW group did not vary significantly across
time points (P = 0.1318), it was higher than in
either CX or CEW+CX at T1 (P < 0.0001 and P
= 0.0265), T2 (P = 0.0011 and P = 0.0084), and
higher than the hematocrit for CEW+CX at T3
(P = 0.019).
Venous oxygen (Figure 3) was lower in the
CX and CEW+CX groups at T1 (P < 0.0001 and
P = 0.0018) and T2 (P < 0.0001 and P = 0.0012)
compared to the CEW group. At T2, pO2 was
also lower in the CX group than the CEW+CX
group (P = 0.0485). By T3, pO2 had returned
to baseline levels for all treatment groups.
Within treatment groups, pO2 did not vary
significantly across time points for CEW+CX.
However, the pO2 for the CX group was lower
at T1 (P = 0.012) and T2 (P = 0014) than at T0.
In the CEW group, pO2 was higher at T1 (P =
0.016) and T2 (P = 0.007) than T0.
There was no significant difference in pCO2
(Figure 3) when comparing treatment groups
at each time point. However, pCO2 did vary
significantly over time within treatment
groups. For the CEW group, pCO2 was lower
at T1 (P = 0.0057) and T2 (P = 0.0008) than at
T0, and for the CEW+CX group, pCO2 was
lower at T1 (P = 0.02) and T2 (P = 0.0136) than
at T3. Additionally, 1 individual in the CX
group had a much higher pCO2 at T1 than
any other individual (pCO2 = 56.8 mm/Hg),
although as a group the pCO2 values did not
vary significantly.
Cardiac troponin I (Figure 3) increased from
baseline at T3 in all groups, although this withingroup increase was only statistically significant
for the CEW and CEW+CX groups (P < 0.0001
for both). Levels of cTnI remained higher at
T4 compared to T0 for CEW (P = 0.0085) and
CEW+CX (P = 0.0005). When comparing results
between treatments at each time point, cTnI
for the CEW+CX group at T3 was greater than
for the other 2 groups (P = 0.0165 compared
to CX and P = 0.0313 compared to CEW). The
between-group differences for CEW and CX
groups were not significant at any time point.
By T4 (24 hours post-exposure), cTnI had
decreased toward baseline levels; there were no
significant differences between groups at T4.
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Figure 3. Mean ± SD for captive reindeer (Rangifer tarandus tarandus) respiratory (venous partial
pressure of oxygen [pO2], carbon dioxide [pCO2])
and cardiac parameters (cardiac troponin I [cTnI])
in blood collected at baseline (T0), 10 min (T1), 20
min (T2), 4 hours (T3), and 24 hours (T4) postexposure to a 10-sec exposure to a conducted electrical weapon (CEW), immobilization with carfentanil/xylazine (CX), or to the CEW while immobilized
with CX (CEW+CX). Open points (Δ = CEW, ○ = CX,
□ = CEW+CX) indicate values that differed significantly (P < 0.05) from T0 for that treatment. Points
with different capital letters indicate treatments that
differed significantly from the other treatments at
that time point. Exposure occurred June 2014 in
Fairbanks, Alaska, USA.

Lactate (Figure 4) increased and was higher
at TC, T1, and T2 (P < 0.0001) than at T0 for all
treatment groups. The increase was similar (and
not significantly different at each time point) in
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Figure 4. Mean ± SD for captive reindeer (Rangifer
tarandus tarandus) blood lactate, blood pH, and
rectal temperature collected at baseline (T0), immediately post-exposure (TC), 10 min (T1), 20 min
(T2), 4 hours (T3), and 24 hours (T4) postexposure to a 10-sec exposure to a conducted electrical weapon (CEW), immobilization with carfentanil/xylazine (CX), or to the CEW while immobilized
with CX (CEW+CX). Open points (Δ = CEW, ○ = CX,
□ = CEW+CX) indicate values that differed significantly (P < 0.05) from T0 for that treatment. Points
with different capital letters indicate treatments that
differed significantly from the other treatments at
that time point. Exposure occurred June 2014 in
Fairbanks, Alaska, USA.

both the CEW and CEW+CX groups. Lactate at
TC, T1, and T2 for the 2 groups treated with the
CEW was higher than the lactate peak for the
CX-only group (P ranged from 0.006–0.0028 for
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CEW compared to CX, and from 0.0094–0.0153
for the CEW+CX comparisons). For all treatment
groups, lactate returned to baseline values by
T3. Although there was a slight decrease in pH
at T1 for the CEW and CEW+CX groups, the
change was not significant (P = 0.3537).
Rectal temperature (Figure 4) increased (P <
0.001) in all groups after exposure to treatment
(TC) and remained elevated through T2. The
increase was greatest for the CX treatment
groups. Temperatures in the CX group were
elevated compared to the CEW group at TC
(P = 0.0481), T2 (P = 0.0085), and approached
significance at T1 (P = 0.0576). The CEW+CX
temperatures were higher from those in
the CEW group at T2 only (P = 0.0101). The
CEW+CX and CX rectal temperatures did not
vary significantly at any time point.

Discussion

For all treatment groups, the observed
changes in lactate, glucose, rectal temperature,
blood oxygen, cardiac troponin I, cortisol, and
catecholamines were transient and returned to
(or approached) baseline levels within 24 hours.
No long-term (>24 hour) or life-threatening
health effects were observed for either restraint
method. All individuals were still alive 1 year
later and had immediately returned to normal
breeding function within the herd (J. Blake,
University of Alaska Animal Research Center,
personal communication).
Creatine kinase is often used as a measure
of muscle stress or damage (both skeletal
and cardiac). It can reversibly increase with
muscle exertion from both handling as well
as exercise. To interpret the results and
determine if increases are normal physiological
responses due to activity or indicative of
a more severe myopathy, levels of other
enzymes (which also might be affected) and
other physiological parameters (like body
temperature) are considered. The increase in
CK between T0 and T3 was within an expected
range due to the physical activity the animals
underwent. Similar values have been reported
in clover-trapped white-tailed deer (Odocoileus
virginianus; Boesch et al. 2011), while much
higher values for CK are reported in roe deer
(Capreolus capreolus) captured with drive nets
(Montane et al. 2003). The 2 individuals with
the highest CK measured at T3, 9632 IU/L and

8032 IU/L (from the CX and CEW+CX groups,
respectively), were noted to have struggled
while getting in the chute (CX individual) or had
a stormy recovery from anesthesia (CEW+CX
individual). These additional exertions can
account for the observed elevations in CK.
There was no evidence of capture myopathy
triggered by any of the treatments in this
study. The higher lactate (and lower pH,
although it was not statistically significant)
seen in the CEW-treated groups are consistent
with the effects of muscle contraction due to
the electronic stimulus. Similar lactate levels
have been reported in clover-trapped whitetailed deer (Boesch et al. 2011), darted moose
(Evans et al. 2012), and in humans after intense
physical activity (Ho et al. 2009b). The greater
increase in rectal temperature in the CX-treated
individuals is consistent with the impaired
thermoregulation caused by the use of opioids
(carfentanil in this case) and especially alpha-2
adrenergic agonists (xylazine in this case). The
observed increases in temperature and lactate
(and decrease in pH) resolved within 24 hours.
No evidence of renal dysfunction (assessed by
BUN and creatinine) was found. Additionally,
all individuals survived and continued to
behave normally after the study.
In addition to impaired thermoregulation, the
use of chemical immobilizing agents has been
associated with impaired cardiopulmonary
function, including respiratory depression,
hypoxemia,
and
decreased
hematocrit
(potentially a result of sequestration of
erythrocytes in the spleen or vasodilation due
to xylazine). The decrease in venous pO2 and
hematocrit observed in the groups treated with
CX is consistent with this. Cardiopulmonary
effects in these individuals resolved after
recovery (by 4 hours post-exposure). The
decrease in blood oxygen observed with
chemical restraint was not present in the
CEW-exposed individuals. The increase in
pO2 seen in the CEW only treated group is
likely due to an increased respiratory rate
observed immediately upon release of the
electrical stimulus. The decreased pCO2 found
in the CEW-exposed group is consistent with
hyperventilation.
Cardiac troponin I is used as a measure of
damage to cardiac muscle. The majority of
cTnI is found within the cardiac muscle and is
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released when the muscle undergoes damage
(e.g., myocardial necrosis). In several species,
myocardial necrosis (including damage caused
by acute coronary syndrome) is characterized
by cTnI levels increasing within 4 hours of
onset of signs, peaking 24–36 hours later, and
decreasing over the course of days to weeks
(Cummins and Cummins 1987, Varga et al.
2009, Agewall et al. 2011). However, it has been
hypothesized that transient (cTnI levels return
to baseline within 24 hours) mild increases
may be due to the cytosolic component rather
than damage leading to necrosis. Between 3%
and 8% of cTnI is unbound in the cytoplasm.
Mild transient increases have been reported
after exercise in human, equine, and canine
endurance runners (Durando et al. 2006,
McKenzie et al. 2007, Nostell and Haggstrom
2008, Gresslien and Agewall 2016) and may
be related to a reversible ischemic event or
a mismatch in the supply and demand for
oxygen (White 2011). Although the mechanism
is not fully understood, it is believed to
be physiological rather than pathological
(Gresslien and Agewall 2016).
Although cTnI was detected and increased
levels were found in some individuals
(especially for the CEW+CX group), the highest
amount detected (0.35 ng/mL) was well below
the levels reported by Varga et al. (2009) as
being associated with myocardial necrosis
(using the same assay) in cattle (Bos taurus;
1.04 ng/ml). Additionally, the slight increases
in our study animals were transient (returning
to baseline within 24 hours), similar to the
exercise-related changes described in other
species (Durando et al. 2006, McKenzie et al.
2007, Gresslien and Agewall 2016). Thus, the
detected cTnI may be cytosolic cTnI rather
than an indication of irreversible damage to
cardiac muscle. The CEW+CX group may have
been affected the most because of the increased
demand for oxygen from the contracting
muscles in response to the CEW coupled
with the decreased heart and breathing rates
caused by the drugs (oxygen supply/demand
mismatch). The significance of the difference in
the CEW group (both for T3 and T4) is likely
due to the limitations of the nonparametric
statistical methodology used (for which ranks
of the measured results are used). The lack of
cTnI detected at T0 in any individuals (unlike
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for the other 2 treatment groups) had a strong
influence on the comparison of rankings.
Glucose, catecholamines (such as norepinephrine and its metabolite, epinephrine), and
cortisol can be used to assess stress in an
individual. Norepinephrine and epinephrine
are part of the sympathetic nervous system
acute response to stress, while cortisol is
associated with the chronic response of the
hypothalamic-pituitary-adrenocortical (HPA)
axis. Glucose is released as a response to
increased levels of cortisol and catecholamines.
The immediate catecholamine response
observed after exposure to the CEW, even
in the group that was also treated with CX,
is consistent with a physiological response,
although a cognitive one (i.e., due to fear or
pain) cannot be ruled out. The mean peak was
similar to the catecholamine response in netgun captured bighorn sheep (Ovis canadensis;
Martucci et al. 1992). In the CEW-exposed
individuals, glucose levels were lower than, and
cortisol levels were similar to levels measured
in clover-trapped white-tailed deer (Boesch et
al. 2011). Cortisol levels were also much lower
than for drive-net captured roe deer (Montane
et al. 2003) and similar to levels measured in
captive reindeer exposed to light restraint or
physical activity (Arnemo and Caulkett 2007).
Exposure to a CEW does not appear to trigger
a greater stress response than current physical
restraint methods. Additionally, all measures
of stress returned to (or approached) baseline
within 4 hours, indicating no prolonged stress
response.
Evaluating relative stress with exposure
to CX is complicated by the effects of the
immobilizing drugs. The alpha-2 adrenergic
agonist used, xylazine, blocks production of
norepinephrine and epinephrine. This results
in respiratory depression, hypotension, and
bradycardia (Sinclair 2003). Additionally,
xylazine decreases insulin release from the
pancreas and increases glucose production
from the liver (gluconeogenesis), resulting in
hyperglycemia (Fagerholm et al. 2011). Thus,
the decreased pO2 and increased glucose
seen in the immobilized individuals is likely
due to xylazine. The inhibitory effect on
norepinephrine is consistent with the lack of a
catecholamine response seen in the CX group.
Additionally, naltrexone is an opioid receptor
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antagonist. It significantly increases cortisol
levels due to blocking the central opioid
receptors (which are inhibitory), resulting in
an activation of the HPA axis. The cortisol
and glucose levels observed in the CX group
are similar to those reported in medetomidine
(a more potent alpha-2 adrenergic agonist)
exposed reindeer (Miller et al. 2013), and CXexposed muskoxen (Ovibos moschatus; Harms et
al. 2012).

Management implications

Most chemical immobilants are delivered to
free-ranging wildlife via remotely projected
darts. Darting, especially with heavy weight
rapid injection darts, entails risks of injury, such
as dart trauma and infections, well beyond mere
immobilization. These effects were mitigated in
this study by hand injection of the drugs (Cattet
et al. 2006). Use of CEWs removes the risk of the
severe morbidity and mortality risks directly
associated with darting and anesthesia.
The risks of using either CEW or chemical
immobilization methods need to be assessed
in relation to the circumstances and necessity
of restraint. Both CEWs and CX have some
physiologic effects that may be considered
beneficial over the other (e.g., better
oxygenation, less thermoregulatory disruption,
decreased risk of bradycardia and bradypnea
with use of CEWs; decreased immediate stress
response with use of chemical immobilants).
Both have strengths and limitations as tools
for effective management of wildlife. While CX
allows for longer handling time for intervention
and can be administered from a longer distance
including from a helicopter, it has more
rigorous training and legal requirements.
The use of a CEW has a very short duration
of immobilization (<1 min), and has a limited
range (<11 m, dependent on cartridge design).
The CEW use, however, is less expensive, more
readily available, has decreased health risks
for the public as well as personnel, does not
expire (cartridges have a 5-year shelf life), and
is insensitive to most environmental conditions
(except extreme cold below -20°C and heat
greater than 50°C).

Acknowledgments

The authors would like to thank the many
people without whom this project would not

have been possible. We are indebted to the
following people for providing their time,
support, and expertise to the study: P. Mooney,
J. Jack, J. Blake, C. Terzi, E. Boone, L. Jones, M.
Lian, G. Del Frate, N. Barten, V. Santana, and D.
Dawes. We also thank L. Clark, HWI associate
editor, as well as several anonymous reviewers
for their valuable feedback. Research was
approved by the University of Alaska Fairbanks
Institutional Animal Care and Use Committee
(protocol number 247563-2).

Literature cited

Alaska Department of Fish and Game. 2010.
III-735: TASER electronic control device use/
safety. Alaska Department of Fish and Game,
Standard Operating Procedures. Alaska Department of Fish and Game, Juneau, Alaska, USA.
Agewall, S., E. Giannitsis, T. Jernberg, and H.
Katus. 2011. Troponin elevation in coronary vs.
non-coronary disease. European Heart Journal
32:404–411.
Arnemo, J. M., and N. A. Caulkett. 2007. Stress.
Pages 103–109 in G. West, S. Heard, and
N. A. Caulkett, editors. Zoo animal and wildlife
immobilization and anesthesia. Blackwell Publishing, Ames, Iowa, USA.
AVMA. 2008. Literature review on the welfare implications of electroimmobilization. American
Veterinary Medical Association, Schaumburg,
Illinois, USA.
AVMA. 2010. Welfare implications of the use of
electro-muscular disruptive devices or “TASER®
devices” on animals. American Veterinary Medical Association, Schaumburg, Illinois, USA.
Boesch, J. M., J. R. Boulanger, P. D. Curtis,
H. N. Erb, J. W. Ludders, M. S. Kraus, and
R. D. Gleed. 2011. Biochemical variables in
free-ranging white-tailed deer (Odocoileus virginianus) after chemical immobilization in clover traps or via ground-darting. Journal of Zoo
and Wildlife Medicine 42:18–28.
Bozeman, W. P., W. E. Hauda, J. J. Heck, D. D.
Graham, B. P. Martin, and J. E. Winslow. 2009.
Safety and injury profile of conducted electrical weapons used by law enforcement officers
against criminal suspects. Annals of Emergency Medicine 53:480–489.
Cattet, M. R., A. Bourque, B. T. Elkin, K. D.
Powley, D. B. Dahlstrom, and N. A. Caulkett.
2006. Evaluation of the potential for injury with
remote drug-delivery systems. Wildlife Society

Conducted electrical weapons • Lieske et al.
Bulletin 34:741–749.
Cummins, B., and P. Cummins. 1987. Cardiac
specific troponin-I release in canine experimental myocardial infarction: development
of a sensitive enzyme-linked immunoassay.
Journal of Molecular and Cellular Cardiology
19:999–1010.
Dawes, D. M., J. D. Ho, and J. R. Miner. 2009.
The neuroendocrine effects of the Taser X26:
a brief report. Forensic Science International
183:14–19.
Durando, M. M., V. B. Reef, K. Kline, and E. K.
Birks. 2006. Acute effects of short duration,
maximal exercise on cardiac troponin I in
healthy horses. Equine and Comparative Exercise Physiology 3:217–223.
Evans, A. L., A. Fahlman, G. Ericsson, H. A. Haga,
and J. M. Arnemo. 2012. Physiological evaluation of free-ranging moose (Alces alces) immobilized with etorphine-xylazine-acepromazine
in northern Sweden. Acta Veterinaria Scandinavica 54:77.
Fagerholm, V., M. Haaparanta, and M. Scheinin.
2011. α2-adrenoceptor regulation of blood glucose homeostasis. Basic and Clinical Pharmacology and Toxicology 108:365–370.
Gresslien, T., and S. Agewall. 2016. Troponin and
exercise. International Journal of Cardiology
221:609–621.
Harms, N. J., B. T. Elkin, A. Gunn, B. Tracz, J.
Adamczewski, P. Flood, and F. Leighton.
2012. Serum biochemistry and serum coritisol
levels of immobilized and hunted muskoxen
(Ovibos moschatus) from northern Canada.
Arctic 65:401–410.
Ho, J. D., D. M. Dawes, L. L. Bultman, R. M.
Moscati, T. A. Janchar, and J. R. Miner. 2009a.
Prolonged TASER use on exhausted humans
does not worsen markers of acidosis. American
Journal of Emergency Medicine 27:413–418.
Ho, J. D., D. M. Dawes, J. B. Cole, J. C. Hottinger,
K. G. Overton, and J. R. Miner. 2009b. Lactate
and pH evaluation in exhausted humans with
prolonged TASER X26 exposure or continued exertion. Forensic Science International
190:80–86.
Ho, J. D., D. M. Dawes, R. S. Nelson, E. J. Lundin,
F. J. Ryan, K. G. Overton, A. J. Zeiders, and
J. R. Miner. 2010. Acidosis and catecholamine
evaluation following simulated law enforcement “use of force” encounters. Academic
Emergency Medicine 17:e60–68.

169
Ho, J. D., D. M. Dawes, R. F. Reardon, A. L.
Lapine, B. J. Dolan, E. J. Lundin, and J. R.
Miner. 2008. Echocardiographic evaluation of
a TASER-X26 application in the ideal human
cardiac axis. Academic Emergency Medicine
15:838–844.
Jauchem, J. R. 2015. Exposures to conducted
electircal weapons (including TASER devices):
how many and for how long are acceptable?
Journal of Forensic Sciences 60:S116–129.
Jauchem, J. R., C. W. Beason, and M. C. Cook.
2009. Acute effects of an alternative electroniccontrol-device waveform in swine. Forensic
Science, Medicine, and Pathology 5:2–10.
Kock, M. D., D. A. Jessup, R. K. Clark, C. E. Franti,
and R. A. Weaver. 1987. Capture methods in
five subspecies of free-ranging bighorn sheep:
an evaluation of drop-net, drive-net, chemical immobilization and the net-gun. Journal of
Wildlife Diseases 23:634–640.
Lewis, L., D. M. Dawes, A. Hinz, and P. Mooney.
2011. TASERs for wildlife? Sometimes, a dose
of electricity may be the best management option. The Wildlife Professional. Spring: 44–46.
Martucci, R. W., D. A. Jessup, G. A. Gronert, J. A.
Reitan, and W. E. Clark. 1992. Blood gas and
catecholamine levels in capture stressed desert bighorn sheep. Journal of Wildlife Diseases
28:250–254.
McKenzie, E. C., E. Jose-Cunilleras, K. W.
Hinchcliff, T. C. Holbrook, C. Royer, M. E.
Payton, K. Williamson, S. Nelson, M. D. Willard, and M. S. Davis. 2007. Serm chemistry
alterations in Alaskan sled dogs during five
successive days of prolonged endurance exercise. Journal of the American Veterinary Medical Association 230:1486–1492.
Miller, A. L., A. L. Evans, O. Os, and J. M. Arnemo.
2013. Biochemical and hematologic reference
values for free-ranging, chemically immobilized
wild Norwegian reindeer (Rangifer tarandus
tarandus) during early winter. Journal of Wildlife Diseases 49:221–228.
Montane, J., I. Marco, J. Lopez-Olvera, D.
Perpinan, X. Manteca, and S. Lavin. 2003. Effects of acepromazine on capture stress in roe
deer (Capreolus capreolus). Journal of Wildlife
Diseases 39:375–386.
Nostell, K., and J. Haggstrom. 2008. Resting concentrations of cardiac troponin I in fit horses
and effect of racing. Journal of Veterinary Cardiology 10:105–109.

170
Sinclair, M. D. 2003. A review of the physiological effects of α2-agonists related to the clinical
use of medetomidine in small animal practice.
Canadian Veterinary Journal 44:885–897.
Smith, M. R., R. J. Kaminski, J. Rojek, G. P.
Alpert, and J. Mathis. 2007. The impact of conducted energy devices and other types of force
and resistance on officer and suspect injuries.
Policing: an International Journal of Police
Strategies and Management 30:423–446.
Varga, A., K. E. Schober, C. H. Holloman, P. C.
Stromberg, J. Lakritz, and D. M. Rings. 2009.
Correlation of serum cardiac troponin I and
myocardial damage in cattle with monensin
toxicosis. Journal of Veterinary Internal Medicine 23:1108–1116.
Walter, R. J., A. J. Dennis, D. J. Valentino, B.
Margeta, K. K. Nagy, F. Bokhari, D. E. Wiley,
K. T. Joseph, and R. R. Roberts. 2008. TASER
x26 discharges in swine produce potentially
fatal ventricular arrhythmias. Academic Emergency Medicine 15:66–73.
White, H. D. 2011. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? Journal of the American College of Cardiology 57:2406–2408.
Williams, E. S., and E. T. Thorne. 1996. Exertional
myopathy (capture myopathy). Pages 181–193
in A. Fairbrother, L. N. Locke, and G. L. Hoff,
editors. Noninfectious diseases of wildlife.
Iowa State University Press, Ames, Iowa, USA.
Associate Editor: Larry Clark

Human–Wildlife Interactions 12(2)

Camilla L. Lieske is a veterinarian with

an interest in the area of wildlife and environmental
health. She is a boardcertified veterinary toxicologist with a master’s degree
in preventive veterinary
medicine. Her research has
focused on epidemiology,
population and environmental
health monitoring, and risk
assessment.

Kimberlee B. Beckmen has been a

wildlife veterinarian with the Alaska Department of
Fish and Game for 15 years.
She heads Alaska’s Wildlife
Health and Disease Surveillance program in addition to
supervising the department’s
wildlife capture and anesthesia operations. Her current
research includes assessing
stress in wildlife captured
by various techniques as well as improving health
monitoring and evaluating new potential drug combinations. She is known for her expertise in terrestrial
wildlife and marine mammal diseases, parasites,
and toxicology.

Larry L. Lewis retired as a wildlife techni-

cian V and fish and game commissioned peace
officer with the Alaska
Department of Fish and
Game, Division of Wildlife
Conservation, after 25
years of public service.
He began working for the
department in 1993 and
specialized in human–
wildlife conflict mitigation
and related governmental
planning, outreach, and
training. He has lectured extensively on human–
wildlife interactions and risk mitigation as well as
wildlife management applications for CEW. He
provides firearms training and both law enforcement
instructor-level and basic end-user CEW training
as well as wildlife usage information for state and
federal agencies and has conducted CEW-related
university-level and extensive hazing and aversive
conditioning field research. He currently owns and
operates Glacier Rivers Consulting and Training LLC,
alaskawildlifesafety.com.

